REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
2,909,600
Share change
+1,740,796
Total reported value
$476,949,313
Price per share
$163.86
Number of holders
56
Value change
+$286,558,836
Number of buys
28
Number of sells
15

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2025

As of 31 Dec 2025, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,909,600 shares. The largest 10 holders included MASSACHUSETTS FINANCIAL SERVICES CO /MA/, CONGRESS ASSET MANAGEMENT CO, RIVERBRIDGE PARTNERS LLC, Allspring Global Investments Holdings, LLC, Retirement Systems of Alabama, Aberdeen Group plc, E. Ohman J:or Asset Management AB, Covea Finance, Sivik Global Healthcare LLC, and BANQUE PICTET & CIE SA. This page lists 56 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.